# Hemodynamic Effects of Chronic Administration of Spironolactone and/or Propranolol in Alcoholic Cirrhotic Patients

> **NCT00188045** · PHASE4 · TERMINATED · sponsor: **University Hospital, Angers** · enrollment: 54 (—)

## Conditions studied

- Alcoholic Cirrhosis

## Interventions

- **DRUG:** Propranolol - Spironolactone

## Key facts

- **NCT ID:** NCT00188045
- **Lead sponsor:** University Hospital, Angers
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1995-04
- **Primary completion:** —
- **Final completion:** 2003-12
- **Target enrollment:** 54 (—)
- **Last updated:** 2017-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00188045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00188045, "Hemodynamic Effects of Chronic Administration of Spironolactone and/or Propranolol in Alcoholic Cirrhotic Patients". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00188045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*